Ballentine Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $688K | Buy |
5,475
+1,651
| +43% | +$207K | 0.01% | 395 |
|
2025
Q1 | $523K | Buy |
3,824
+1,384
| +57% | +$189K | 0.01% | 434 |
|
2024
Q4 | $373K | Buy |
2,440
+911
| +60% | +$139K | 0.01% | 510 |
|
2024
Q3 | $296K | Sell |
1,529
-1,805
| -54% | -$350K | 0.01% | 596 |
|
2024
Q2 | $773K | Buy |
3,334
+1,667
| +100% | +$386K | 0.01% | 317 |
|
2024
Q1 | $359K | Buy |
1,667
+18
| +1% | +$3.88K | 0.01% | 487 |
|
2023
Q4 | $427K | Buy |
1,649
+121
| +8% | +$31.3K | 0.01% | 405 |
|
2023
Q3 | $393K | Buy |
1,528
+48
| +3% | +$12.3K | 0.01% | 367 |
|
2023
Q2 | $422K | Buy |
1,480
+59
| +4% | +$16.8K | 0.01% | 356 |
|
2023
Q1 | $395K | Sell |
1,421
-60
| -4% | -$16.7K | 0.01% | 349 |
|
2022
Q4 | $410K | Sell |
1,481
-1
| -0.1% | -$277 | 0.01% | 316 |
|
2022
Q3 | $395K | Buy |
1,482
+307
| +26% | +$81.8K | 0.01% | 282 |
|
2022
Q2 | $241K | Sell |
1,175
-71
| -6% | -$14.6K | 0.01% | 364 |
|
2022
Q1 | $263K | Sell |
1,246
-77
| -6% | -$16.3K | 0.01% | 380 |
|
2021
Q4 | $317K | Buy |
1,323
+172
| +15% | +$41.2K | 0.01% | 356 |
|
2021
Q3 | $326K | Sell |
1,151
-162
| -12% | -$45.9K | 0.01% | 311 |
|
2021
Q2 | $454K | Sell |
1,313
-97
| -7% | -$33.5K | 0.02% | 249 |
|
2021
Q1 | $395K | Sell |
1,410
-39
| -3% | -$10.9K | 0.01% | 256 |
|
2020
Q4 | $355K | Sell |
1,449
-3,835
| -73% | -$940K | 0.01% | 253 |
|
2020
Q3 | $1.5M | Sell |
5,284
-1,651
| -24% | -$469K | 0.07% | 101 |
|
2020
Q2 | $1.86M | Sell |
6,935
-54
| -0.8% | -$14.4K | 0.09% | 90 |
|
2020
Q1 | $2.21M | Buy |
6,989
+58
| +0.8% | +$18.3K | 0.13% | 70 |
|
2019
Q4 | $2.06M | Buy |
6,931
+4,918
| +244% | +$1.46M | 0.09% | 88 |
|
2019
Q3 | $468K | Buy |
2,013
+48
| +2% | +$11.2K | 0.02% | 214 |
|
2019
Q2 | $460K | Buy |
1,965
+23
| +1% | +$5.38K | 0.02% | 222 |
|
2019
Q1 | $459K | Sell |
1,942
-7
| -0.4% | -$1.65K | 0.02% | 198 |
|
2018
Q4 | $587K | Sell |
1,949
-278
| -12% | -$83.7K | 0.03% | 176 |
|
2018
Q3 | $787K | Sell |
2,227
-1,877
| -46% | -$663K | 0.04% | 152 |
|
2018
Q2 | $1.19M | Buy |
4,104
+56
| +1% | +$16.3K | 0.07% | 94 |
|
2018
Q1 | $1.11M | Buy |
4,048
+2,171
| +116% | +$595K | 0.06% | 96 |
|
2017
Q4 | $598K | Buy |
1,877
+202
| +12% | +$64.4K | 0.03% | 169 |
|
2017
Q3 | $525K | Sell |
1,675
-20
| -1% | -$6.27K | 0.03% | 187 |
|
2017
Q2 | $480K | Buy |
1,695
+368
| +28% | +$104K | 0.04% | 201 |
|
2017
Q1 | $364K | Sell |
1,327
-446
| -25% | -$122K | 0.03% | 158 |
|
2016
Q4 | $495K | Sell |
1,773
-139
| -7% | -$38.8K | 0.04% | 115 |
|
2016
Q3 | $599K | Sell |
1,912
-53
| -3% | -$16.6K | 0.05% | 83 |
|
2016
Q2 | $476K | Buy |
1,965
+154
| +9% | +$37.3K | 0.04% | 116 |
|
2016
Q1 | $472K | Buy |
1,811
+507
| +39% | +$132K | 0.04% | 113 |
|
2015
Q4 | $400K | Sell |
1,304
-105
| -7% | -$32.2K | 0.04% | 111 |
|
2015
Q3 | $412K | Buy |
1,409
+208
| +17% | +$60.8K | 0.04% | 101 |
|
2015
Q2 | $485K | Buy |
1,201
+44
| +4% | +$17.8K | 0.05% | 92 |
|
2015
Q1 | $488K | Sell |
1,157
-10
| -0.9% | -$4.22K | 0.05% | 89 |
|
2014
Q4 | $396K | Sell |
1,167
-131
| -10% | -$44.5K | 0.05% | 107 |
|
2014
Q3 | $429K | Buy |
1,298
+111
| +9% | +$36.7K | 0.05% | 93 |
|
2014
Q2 | $374K | Sell |
1,187
-39
| -3% | -$12.3K | 0.04% | 99 |
|
2014
Q1 | $375K | Buy |
1,226
+56
| +5% | +$17.1K | 0.04% | 98 |
|
2013
Q4 | $327K | Buy |
1,170
+80
| +7% | +$22.4K | 0.04% | 111 |
|
2013
Q3 | $262K | Buy |
+1,090
| New | +$262K | 0.03% | 118 |
|